FILE - In this Thursday, April 19, 2012 file photo Nestle's CEO Paul Bulcke speaks during the general meeting of one of the world's leading food and beverage company, Nestle Group, in Lausanne, Switzerland. Nestle SA announced a deal Monday, April 23, 2012, to acquire Pfizer Inc.'s infant-nutrition business for US$11.85 billion in a bid to boost sales in emerging markets. (AP Photo/Keystone, Jean-Christophe Bott, File)

Associated Press
FILE - In this Thursday, April 19, 2012 file photo Nestle's CEO Paul Bulcke speaks during the general meeting of one of the world's leading food and beverage company, Nestle Group, in Lausanne, Switzerland. Nestle SA announced a deal Monday, April 23, 2012, to acquire Pfizer Inc.'s infant-nutrition business for US$11.85 billion in a bid to boost sales in emerging markets. (AP Photo/Keystone, Jean-Christophe Bott, File)
FILE - In this Thursday, April 19, 2012 file photo Nestle's CEO Paul Bulcke speaks during the general meeting of one of the world's leading food and beverage company, Nestle Group, in Lausanne, Switzerland. Nestle SA announced a deal Monday, April 23, 2012, to acquire Pfizer Inc.'s infant-nutrition business for US$11.85 billion in a bid to boost sales in emerging markets. (AP Photo/Keystone, Jean-Christophe Bott, File)
View Comments (0)